MedTrace Logo

Utility of an APP for the Monitoring of Irruptive Oncological Pain

NCT03597737 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2021-04-12

No results posted yet for this study

Summary

The present investigation aims at exploring the effect of including a pain app called Pain Monitor irruptive oncological pain for chronic pain patients' daily monitoring. Two conditions will be set:

1. usual treatment (waiting list)
2. usual treatment + APP

Conditions

Interventions

DEVICE

Pain APP

pain app Pain Monitor app has been developed by a multidisciplinary pain expert panel, including physicians, psychologists, and nurses. Content has been validated in a previous study and usability has been shown to be excellent.

Sponsors & Collaborators

  • Universitat Jaume I

    lead OTHER

Principal Investigators

  • Azucena García-Palacios, PhD · Universitat Jaume I

Study Design

Allocation
NON_RANDOMIZED
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-10
Primary Completion
2019-03-28
Completion
2020-11-29

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03597737 on ClinicalTrials.gov